Gedye, Craig <br/><br/>
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Oct 2009 
 - 1635-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-009-0672-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Antigens, CD--metabolism<br/>Antigens, Neoplasm--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--therapeutic use<br/>Colony-Forming Units Assay<br/>Cytotoxicity, Immunologic<br/>Fluorescent Antibody Technique<br/>Glycoproteins--metabolism<br/>HLA-A2 Antigen--genetics<br/>Humans<br/>Immunoenzyme Techniques<br/>Lymphatic Metastasis<br/>Male<br/>Melanoma--immunology<br/>Membrane Proteins--immunology<br/>Peptide Fragments--immunology<br/>Peptides--metabolism<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Skin Neoplasms--immunology<br/>T-Lymphocytes, Cytotoxic--immunology